Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Acrivon Therapeutics Inc (NASDAQ: ACRV) closed the day trading at $2.61 down -51.58% from the previous closing price of $5.39. In other words, the price has decreased by -$51.58 from its previous closing price. On the day, 1.85 million shares were traded. ACRV stock price reached its highest trading level at $4.42 during the session, while it also had its lowest trading level at $2.52.
Ratios:
For a better understanding of ACRV, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.75 and its Current Ratio is at 12.75. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On September 16, 2024, Ladenburg Thalmann Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 11 ’24 when PERCEPTIVE ADVISORS LLC bought 2,353,000 shares for $8.50 per share. The transaction valued at 20,000,500 led to the insider holds 5,360,858 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACRV now has a Market Capitalization of 81265736 and an Enterprise Value of -15615365.
Stock Price History:
The Beta on a monthly basis for ACRV is 0.80, which has changed by -0.16627997 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, ACRV has reached a high of $11.90, while it has fallen to a 52-week low of $4.69. The 50-Day Moving Average of the stock is -52.33%, while the 200-Day Moving Average is calculated to be -62.36%.
Shares Statistics:
Over the past 3-months, ACRV traded about 48.77K shares per day on average, while over the past 10 days, ACRV traded about 26810 shares per day. A total of 31.13M shares are outstanding, with a floating share count of 21.60M. Insiders hold about 30.63% of the company’s shares, while institutions hold 66.63% stake in the company. Shares short for ACRV as of 1741910400 were 730574 with a Short Ratio of 14.98, compared to 1739491200 on 1132370. Therefore, it implies a Short% of Shares Outstanding of 730574 and a Short% of Float of 6.1100002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
At present, 5.0 analysts are actively evaluating the performance of Acrivon Therapeutics Inc (ACRV) in the stock market.The consensus estimate for the next quarter is -$0.71, with high estimates of -$0.63 and low estimates of -$0.85.
Analysts are recommending an EPS of between -$2.42 and -$3.07 for the fiscal current year, implying an average EPS of -$2.6. EPS for the following year is -$2.66, with 6.0 analysts recommending between -$2.0 and -$3.84.
